HCPLive Network
Latest Gastroenterology Headlines
Thursday, November 27, 2014
By Rachel Lutz
Dronabinol, commonly used as a nausea treatment, could be effective treatment for non-cardiac chest pain patients.
Tuesday, November 25, 2014
By Amy Jacob
Study results published in the European Respiratory Journal show that rates of inflammatory bowel disease (IBD) incidence have significantly increased in individuals with asthma or chronic obstructive pulmonary disease (COPD).
Tuesday, November 25, 2014
For patients with functional constipation, perineal self-acupressure is associated with improved quality of life and bowel function, according to a study published online Nov. 10 in the Journal of General Internal Medicine.
Tuesday, November 25, 2014
Data suggest that gentler, thoughtful approach helps boost patient outcomes
Monday, November 24, 2014
Millions of Americans bought health insurance coverage through the Affordable Care Act in the past year and physicians may be reluctant to accept these patients.
Monday, November 24, 2014
Gender inequality still exists in medicine, according to an article published by the American Medical Association.
Friday, November 21, 2014
By Amy Jacob
Patients with advanced colorectal cancer previously only had access to limited treatment options; however, new research presented at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, indicated a combination of 3 targeted drugs could potentially serve as a successful treatment.
Friday, November 21, 2014
The effects of trials to improve medication adherence are inconsistent, with few studies of the highest quality demonstrating improvement in both adherence and clinical outcome, according to a review published online Nov. 20 in The Cochrane Library.
Friday, November 21, 2014
By Catherine Kolonko
The maker of Sovriad (simeprevir) has revised the drug's package insert labeling on the order of Japanese health officials following the deaths of three people who took the hepatitis C drug.
Friday, November 21, 2014
By Catherine Kolonko
Patients with cirrhosis who took part in a study that tested a triple combination drug for hepatitis C with ribavirin saw normalization of key laboratory tests after three and six month treatment periods, an indication of improved liver condition.
Email Signup
Physician's Money Digest
Americans have long loved their televisions, but the silver screen now plays second fiddle to a decidedly smaller screen.
With the advent of ongoing audits for medical necessity and accurate coding, whose documentation is being scrutinized to ensure that the medical services being provided are reasonable and necessary? The answer: physicians.